Annual Working Capital
$238.37 M
+$20.57 M+9.45%
31 December 2023
Summary:
Pharming Group NV annual working capital is currently $238.37 million, with the most recent change of +$20.57 million (+9.45%) on 31 December 2023. During the last 3 years, it has risen by +$52.01 million (+27.91%). PHAR annual working capital is now at all-time high.PHAR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$202.35 M
+$11.66 M+6.11%
30 September 2024
Summary:
Pharming Group NV quarterly working capital is currently $202.35 million, with the most recent change of +$11.66 million (+6.11%) on 30 September 2024. Over the past year, it has dropped by -$21.33 million (-9.53%). PHAR quarterly working capital is now -15.11% below its all-time high of $238.37 million, reached on 31 December 2023.PHAR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.4% | -9.5% |
| 3 y3 years | +27.9% | +3.5% |
| 5 y5 years | +534.5% | +1482.8% |
PHAR Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.9% | -15.1% | +126.7% |
| 5 y | 5 years | at high | +4500.9% | -15.1% | +3805.7% |
| alltime | all time | at high | +2260.7% | -15.1% | +1090.7% |
Pharming Group NV Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $202.35 M(+6.1%) |
| June 2024 | - | $190.69 M(+113.6%) |
| Mar 2024 | - | $89.27 M(-62.6%) |
| Dec 2023 | $238.37 M(+9.4%) | $238.37 M(+6.6%) |
| Sept 2023 | - | $223.68 M(+4.7%) |
| June 2023 | - | $213.62 M(+3.2%) |
| Mar 2023 | - | $207.05 M(-4.9%) |
| Dec 2022 | $217.80 M(+7.5%) | $217.80 M(+6.1%) |
| Sept 2022 | - | $205.35 M(-1.2%) |
| June 2022 | - | $207.79 M(+1.0%) |
| Mar 2022 | - | $205.80 M(+1.5%) |
| Dec 2021 | $202.67 M(+8.8%) | $202.67 M(+3.7%) |
| Sept 2021 | - | $195.48 M(-3.9%) |
| June 2021 | - | $203.42 M(+8.1%) |
| Mar 2021 | - | $188.12 M(+0.9%) |
| Dec 2020 | $186.36 M(+3497.0%) | $186.36 M(-1.5%) |
| Sept 2020 | - | $189.16 M(+11.0%) |
| June 2020 | - | $170.39 M(+14.9%) |
| Mar 2020 | - | $148.36 M(+2763.5%) |
| Dec 2019 | $5.18 M(-86.2%) | $5.18 M(-59.5%) |
| Sept 2019 | - | $12.78 M(-68.1%) |
| June 2019 | - | $40.07 M(-9.5%) |
| Mar 2019 | - | $44.27 M(+17.8%) |
| Dec 2018 | $37.57 M(+13.8%) | $37.57 M(+10.5%) |
| Sept 2018 | - | $34.00 M(-28.5%) |
| June 2018 | - | $47.52 M(+9.1%) |
| Mar 2018 | - | $43.54 M(+31.9%) |
| Dec 2017 | $33.00 M(+190.2%) | $33.00 M(+60.4%) |
| Sept 2017 | - | $20.58 M(-32.5%) |
| June 2017 | - | $30.49 M(+532.1%) |
| Mar 2017 | - | $4.82 M(-57.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $11.37 M(-72.4%) | $11.37 M(-55.4%) |
| Sept 2016 | - | $25.50 M(-17.7%) |
| June 2016 | - | $30.99 M(-16.8%) |
| Mar 2016 | - | $37.25 M(-9.4%) |
| Dec 2015 | $41.13 M(-1.3%) | $41.13 M(-12.5%) |
| Sept 2015 | - | $46.98 M(+34.6%) |
| June 2015 | - | $34.91 M(-3.2%) |
| Mar 2015 | - | $36.07 M(-13.4%) |
| Dec 2014 | $41.67 M(+158.5%) | $41.67 M(+54.3%) |
| Sept 2014 | - | $27.00 M(+9.8%) |
| June 2014 | - | $24.59 M(+33.3%) |
| Mar 2014 | - | $18.46 M(+14.5%) |
| Dec 2013 | $16.12 M(-2448.5%) | $16.12 M(+102.1%) |
| Sept 2013 | - | $7.97 M(+1.6%) |
| June 2013 | - | $7.85 M(-748.7%) |
| Mar 2013 | - | -$1.21 M(+76.3%) |
| Dec 2012 | -$686.40 K(-110.5%) | -$686.40 K(-84.7%) |
| Sept 2012 | - | -$4.50 M(-243.4%) |
| Mar 2012 | - | $3.13 M(-51.9%) |
| Dec 2011 | $6.51 M(-75.0%) | $6.51 M(-49.0%) |
| Sept 2011 | - | $12.78 M(-25.3%) |
| June 2011 | - | $17.11 M(-26.0%) |
| Mar 2011 | - | $23.11 M(-11.2%) |
| Dec 2010 | $26.02 M(-335.8%) | $26.02 M(+78.2%) |
| Sept 2010 | - | $14.60 M(-283.1%) |
| June 2010 | - | -$7.98 M(-61.0%) |
| Mar 2010 | - | -$20.43 M(+85.1%) |
| Dec 2009 | -$11.03 M(-133.8%) | -$11.03 M |
| Dec 2008 | $32.61 M(-59.4%) | - |
| Dec 2007 | $80.41 M(+83.5%) | - |
| Dec 2006 | $43.83 M(+86.8%) | - |
| Dec 2005 | $23.46 M | - |
FAQ
- What is Pharming Group NV annual working capital?
- What is the all time high annual working capital for Pharming Group NV?
- What is Pharming Group NV annual working capital year-on-year change?
- What is Pharming Group NV quarterly working capital?
- What is the all time high quarterly working capital for Pharming Group NV?
- What is Pharming Group NV quarterly working capital year-on-year change?
What is Pharming Group NV annual working capital?
The current annual working capital of PHAR is $238.37 M
What is the all time high annual working capital for Pharming Group NV?
Pharming Group NV all-time high annual working capital is $238.37 M
What is Pharming Group NV annual working capital year-on-year change?
Over the past year, PHAR annual working capital has changed by +$20.57 M (+9.45%)
What is Pharming Group NV quarterly working capital?
The current quarterly working capital of PHAR is $202.35 M
What is the all time high quarterly working capital for Pharming Group NV?
Pharming Group NV all-time high quarterly working capital is $238.37 M
What is Pharming Group NV quarterly working capital year-on-year change?
Over the past year, PHAR quarterly working capital has changed by -$21.33 M (-9.53%)